tiprankstipranks
Trending News
More News >
Universal Ibogaine Inc (TSE:IBO)
:IBO

Universal Ibogaine Inc (IBO) Price & Analysis

Compare
10 Followers

IBO Stock Chart & Stats


Financials

IBO FAQ

What was Universal Ibogaine Inc’s price range in the past 12 months?
Universal Ibogaine Inc lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
    What is Universal Ibogaine Inc’s market cap?
    Universal Ibogaine Inc’s market cap is C$6.87M.
      When is Universal Ibogaine Inc’s upcoming earnings report date?
      Universal Ibogaine Inc’s upcoming earnings report date is Mar 27, 2026 which is in 257 days.
        How were Universal Ibogaine Inc’s earnings last quarter?
        Universal Ibogaine Inc released its earnings results on Jun 27, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
          Is Universal Ibogaine Inc overvalued?
          According to Wall Street analysts Universal Ibogaine Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Universal Ibogaine Inc pay dividends?
            Universal Ibogaine Inc does not currently pay dividends.
            What is Universal Ibogaine Inc’s EPS estimate?
            Universal Ibogaine Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Universal Ibogaine Inc have?
            Universal Ibogaine Inc has 274,825,740 shares outstanding.
              What happened to Universal Ibogaine Inc’s price movement after its last earnings report?
              Universal Ibogaine Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Universal Ibogaine Inc?
                Currently, no hedge funds are holding shares in TSE:IBO

                Company Description

                Universal Ibogaine Inc

                Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
                Similar Stocks
                Company
                Price & Change
                Follow
                Core One Labs
                Britannia Life Sciences Inc
                HAVN Life Sciences
                MYND Life Sciences
                Awakn Life Sciences
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis